Calypso Biotech: String of successes for Merck Serono spin-offs
Continuing the success story of Merck Serono spin-offs, Calypso Biotech has closed a €20 million financing round. The funds will be used to advance its lead molecule to the clinic.
Read full article »
Calypso Biotech is a Netherlands-based biotechnology company that researches and develops monoclonal antibodies for the treatment of autoimmune diseases.
Read more